Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

MeiraGTx Announces FDA FDA Regenerative Medicine Advanced Therapy Designation For AAV2-hAQP1 In Treatment Of Grade 2/3 Radiation-Induced Xerostomia

Author: Benzinga Newsdesk | December 09, 2024 09:01am

Posted In: MGTX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist